0000049071-18-000043.txt : 20180227 0000049071-18-000043.hdr.sgml : 20180227 20180227183817 ACCESSION NUMBER: 0000049071-18-000043 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180224 FILED AS OF DATE: 20180227 DATE AS OF CHANGE: 20180227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Christopher M Todoroff CENTRAL INDEX KEY: 0001441437 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-05975 FILM NUMBER: 18647226 MAIL ADDRESS: STREET 1: HUMANA INC. STREET 2: 500 WEST MAIN STREET CITY: LOUISVILLE STATE: KY ZIP: 40202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANA INC CENTRAL INDEX KEY: 0000049071 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 610647538 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 W MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 BUSINESS PHONE: 5025801000 MAIL ADDRESS: STREET 1: 500 W. MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 FORMER COMPANY: FORMER CONFORMED NAME: EXTENDICARE INC DATE OF NAME CHANGE: 19740404 FORMER COMPANY: FORMER CONFORMED NAME: HERITAGE HOUSE OF AMERICA INC DATE OF NAME CHANGE: 19671129 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2018-02-24 0000049071 HUMANA INC HUM 0001441437 Christopher M Todoroff HUMANA INC. 500 WEST MAIN STREET LOUISVILLE KY 40202 0 1 0 0 Chief Legal Officer Humana Common 2018-02-24 4 M 0 4472 0 A 13447 D Humana Common 2018-02-24 4 F 0 1575 269.31 D 11872 D Humana Common 2018-02-27 4 M 0 7005 164.645 A 18877 D Humana Common 2018-02-27 4 M 0 6935 167.805 A 25812 D Humana Common 2018-02-27 4 S 0 16389 273.3724 D 9423 D Options 164.645 2018-02-27 4 M 0 7005 0 D 2022-02-24 Humana Common 7005 0 D Options 167.805 2018-02-27 4 M 0 6935 0 D 2023-02-18 Humana Common 6935 6935 D Options 217.415 2024-03-08 Humana Common 15498 15498 D Options 239.12 2024-06-28 Humana Common 7366 7366 D Options 268.47 2025-02-19 Humana Common 6221 6221 D Restricted Stock Units Humana Common 1540 1540 D Restricted Stock Units Humana Common 2377 2377 D Restricted Stock Units Humana Common 1620 1620 D Restricted Stock Units Humana Common 1443 1443 D Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/15, vesting in three increments from 02/24/16 to 02/24/18. Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/16, vesting in three increments from 02/18/17 to 02/18/19. Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017, vesting in three annual increments. Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 06/28/2017, 100% of the award is vesting on 06/28/20 Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/19/18, vesting in three increments from 02/19/19 to 02/19/21. Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18. Reporting Person disclaims Beneficial Ownership of one-half of each option or restricted stock unit held as of December 2016 pursuant to Divorce Decree, exempt under Rule 16a-12. Restricted stock units granted to reporting person on 03/08/2017, 33% of the award is vesting on 12/15/17, 12/15/18, and 12/15/19. Restricted stock units granted to reporting person on 06/28/17, 100% of the award is vesting on 06/28/20. Restricted stock units granted to reporting person on 02/19/18, 33% of the award is vesting on 12/15/18, 12/15/19, and 12/15/20. Includes Performance Stock Units that vested on 2/24/2018. Shares sold from prices ranging from $273.10422 to $275.75. Price reported is weighted avg sales price. Christopher M. Todoroff 2018-02-27